Sudarshan Chemical Industries LtdQ1 FY27
Sudarshan Chemical Industries Ltd Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹1,257P/E: 95.2Market Cap: ₹9.7K CrSector: Chemicals & Petrochemicals
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- →The company projects reaching Rs.12,000 Crores+ in revenue post-Heubach acquisition, indicating aggressive growth potential (Page 14).
- →Growth is expected from recapturing lost business due to past integration challenges within Heubach (Page 14).
- →Revenue growth is anticipated to be in high single digits to low double digits for the acquired group, not a uniform 15% (Page 13).
- →Legacy Sudarshan business is expected to continue growing at around 12%-13% (Page 5).
- →Management expects a revenue CAGR of 5%-7% over the next 2-3 years, split between volume and value growth driven by premiumization (Page 8).
- →The company is focused on profitable growth, avoiding hampering gross margins, emphasizing value capture and cost efficiencies (Page 9).
- →Challenges like subdued demand in US/Europe coatings and plastics are seen as short-term; specialty segments show good growth potential (Page 10).
- →Volume growth has been modest (~6% in Q1), with confidence rooted in business recovery and value capture initiatives (Page 6).
Margin guidance
Category 3- →Sudarshan expects a revenue CAGR of 5% to 7% over the next 2-3 years, with a focus on profitable growth rather than aggressive topline expansion.
- →The acquired business (Heubach) is projected to reach Rs.12,000 Crores+ in revenue by FY2029.
- →EBITDA growth is anticipated to be strong, with doubling of EBITDA closer to FY2029, driven by cost reduction and value capture initiatives.
- →Historically, the acquired entity has achieved double-digit EBITDA margins, and similar performance is expected going forward.
- →Earnings per share (EPS) for Q1 FY2027 was Rs.12.3 (not annualized), reflecting strong profitability.
- →Return on Capital Employed is high at 22.7%.
- →Management aims for sustainable EBITDA margin improvements and reducing net debt further, aspiring for a debt-free position.
- →Overall, confidence is high on delivering robust, profitable growth with ongoing efficiency and integration benefits.
Fundraise plans
- →No explicit plans for new fundraising through debt or equity were mentioned in the call.
- →The company is focused on reducing acquisition-related debt, having already reduced it from Rs. 922 Crores to Rs. 531 Crores within 18 months.
- →They plan to continue accelerating debt repayment as net debt position improves.
- →For capex, the company indicated no need for major new capacity-related investments, only moderate capex for special projects based on ROI.
- →The emphasis is on working capital release, cost reduction, and value capture rather than raising additional capital.
- →Overall, the company aims to become debt-free in the future and improve leverage steadily without immediate plans for new fundraising.
Order book
The transcript does not explicitly mention the current or expected order book or pending orders for Sudarshan Chemical Industries Limited. However, some relevant points about business momentum and demand are:
- Q1 FY2027 revenue was strong at Rs. 2,642 Crores, slightly above guidance.
- There have been some execution challenges in the RIECO business impacting revenue and EBITDA.
- Business growth is supported by recovering lost customers and gaining business in intercompany transfers.
- The company is navigating geopolitical uncertainties impacting demand and supply chain.
- Customers in many industries are delaying purchases and unwilling to build high inventory.
- Procurement ensures adequate safety stock with optimized logistics.
- The company remains confident in achieving its revenue and EBITDA guidance for FY2027 and beyond.
- They observe some short-term subdued demand in coatings (US and Europe) and cyclic demand in plastics.
Overall, while specific order book or pending order numbers are not provided, the company signals stable demand with some supply chain and market uncertainties.
Capex plans
Yes- →No substantial new capex is expected in the near term as current capacities are sufficient to support indicated growth.
- →Moderate capex may be undertaken for special initiatives such as backward integration or new special projects.
- →Any new investments will be driven by ROI considerations; only projects with good returns will be pursued.
- →The company is implementing Project Integra (One SAP) in the current financial year to harmonize reporting systems, which is a strategic investment in IT infrastructure.
- →Capital expenditure is thus focused on efficiency, integration, and select value-adding projects rather than large-scale capacity expansion.
Track Sudarshan Chemical Industries Ltd — get its next earnings analysis in your feed
Margin guidance
Category 3- →Sudarshan expects a revenue CAGR of 5% to 7% over the next 2-3 years, with a focus on profitable growth rather than aggressive topline expansion.
- →The acquired business (Heubach) is projected to reach Rs.12,000 Crores+ in revenue by FY2029.
- →EBITDA growth is anticipated to be strong, with doubling of EBITDA closer to FY2029, driven by cost reduction and value capture initiatives.
- →Historically, the acquired entity has achieved double-digit EBITDA margins, and similar performance is expected going forward.
- →Earnings per share (EPS) for Q1 FY2027 was Rs.12.3 (not annualized), reflecting strong profitability.
- →Return on Capital Employed is high at 22.7%.
- →Management aims for sustainable EBITDA margin improvements and reducing net debt further, aspiring for a debt-free position.
- →Overall, confidence is high on delivering robust, profitable growth with ongoing efficiency and integration benefits.
Order book
The transcript does not explicitly mention the current or expected order book or pending orders for Sudarshan Chemical Industries Limited. However, some relevant points about business momentum and demand are:
- Q1 FY2027 revenue was strong at Rs. 2,642 Crores, slightly above guidance.
- There have been some execution challenges in the RIECO business impacting revenue and EBITDA.
- Business growth is supported by recovering lost customers and gaining business in intercompany transfers.
- The company is navigating geopolitical uncertainties impacting demand and supply chain.
- Customers in many industries are delaying purchases and unwilling to build high inventory.
- Procurement ensures adequate safety stock with optimized logistics.
- The company remains confident in achieving its revenue and EBITDA guidance for FY2027 and beyond.
- They observe some short-term subdued demand in coatings (US and Europe) and cyclic demand in plastics.
Overall, while specific order book or pending order numbers are not provided, the company signals stable demand with some supply chain and market uncertainties.
How does Sudarshan Chemical Industries Ltd rank vs peers in Chemicals & Petrochemicals?
Pro feature1Sudarshan Chemical Industries Ltd
Rev 3Mar 3
See full Chemicals & Petrochemicals sector rankings
How does Sudarshan Chemical Industries Ltd rank in Chemicals & Petrochemicals?
Compare Sudarshan Chemical Industries Ltd against every Chemicals & Petrochemicals company (Q1 FY27) on revenue, margins and earnings-call signals.